Roflumilast mitigates cisplatin-induced nephrotoxicity by regulating TNF-α/TNFR1/TNFR2/Fas/Caspase mediated apoptosis and inflammatory signals
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgae142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Priyal Patel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Anand, Gujarat 388421, India. Hauptthemen laut MEDLINE: Cisplatin, Benzamides, Apoptosis, Aminopyridines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Purpose
The study aimed to evaluate the effect of roflumilast on modulating TNF-α/Caspase mediated cellular signals in cisplatin-induced nephrotoxicity in rats.
Methods
The rats (Male Wistar) were divided into five groups: normal control, disease control (cisplatin: 7 mg/kg i.p.), and cisplatin + roflumilast (0.25, 0.5, and 1 mg/kg b.w., p.o.). Cisplatin was administrated to rats on 0 day, and roflumilast treatment was started from the 6th–15th days. Blood and tissue were collected. Tissue was used to measure oxidative stress, such as malondialdehyde, superoxide dismutase, and catalase. Gene expression study involved real-time PCR of key genes linked with inflammation and apoptosis, i.e. Tnf-α, Tnfr1, Tnfr2, Fas, Nfkb, Casp3, Casp8, and Nrf2.
Findings
Cisplatin showed decreased serum creatinine and urea, high albumin, and total protein. Cisplatin elevated the malondialdehyde and reduced superoxide dismutase and catalase activity. Cisplatin also attributed an overexpression of Tnf-α, Tnfr1, Tnfr2, Nfkb, Fas, Casp3, and Casp8, and a decrease in the Nrf2 gene. Roflumilast decreased creatinine and urea and increased albumin and total protein levels. Roflumilast also downregulated the expression of Tnf-α, Tnfr1, Tnfr2, Nfkb, Fas, Casp3, and Casp8 and upregulated the Nrf2 gene expression.
Conclusion
Roflumilast manifested as a potential reno-protective agent against cisplatin-induced nephrotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Anand, Gujarat 388421, India.
- Department of Pharmacology, L.M. College of Pharmacy, Ahmedabad, Gujarat 380009, India.
- Department of Clinical Pharmacy, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Anand, Gujarat 388421, India.
- Department of Research and Development, Sat-Kaival Hospital Pvt. Ltd, Anand, Gujarat 388001, India.
- Department of Pathology, Muljibhai Patel Urological Hospital, Nadiad, Gujarat 387002, India.
- Department of Pharmaceutical Chemistry and Analysis, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Anand, Gujarat 388421, India.
ORCID-Profile: Samir Patel, Manan Raval
Zitieren
APA
Patel, P., Patel, S., Patel, Y., Chudasama, P., Soni, S., Patel, S., & Raval, M. (2025). Roflumilast mitigates cisplatin-induced nephrotoxicity by regulating TNF-α/TNFR1/TNFR2/Fas/Caspase mediated apoptosis and inflammatory signals. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae142
Vancouver
Patel P, Patel S, Patel Y, Chudasama P, Soni S, Patel S, et al. Roflumilast mitigates cisplatin-induced nephrotoxicity by regulating TNF-α/TNFR1/TNFR2/Fas/Caspase mediated apoptosis and inflammatory signals. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgae142
BibTeX
@article{Patel2025,
author = {Patel, Priyal and Patel, Sandip and Patel, Yash and Chudasama, Piyush and Soni, Shailesh and Patel, Samir and Raval, Manan},
title = {Roflumilast mitigates cisplatin-induced nephrotoxicity by regulating TNF-α/TNFR1/TNFR2/Fas/Caspase mediated apoptosis and inflammatory signals},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgae142}
}
EUVIMED